Global Fc Protein and Glycoengineered Antibodies Sales Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 126
Inquire Before Buying

Notes:

Sales, means the sales volume of Fc Protein and Glycoengineered Antibodies

Revenue, means the sales value of Fc Protein and Glycoengineered Antibodies

This report studies sales (consumption) of Fc Protein and Glycoengineered Antibodies in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Roche

- TG Therapeutics

- MedImmune/AstraZeneca

- LFB Biotechnologies

- Glycotope

- Mentrik Biotech

- MacroGenics

- MorphoSys

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Fc Protein and Glycoengineered Antibodies in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Fc Protein and Glycoengineered Antibodies in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Fc Protein and Glycoengineered Antibodies Sales Market Report 2016

Table of Contents
Global Fc Protein and Glycoengineered Antibodies Sales Market Report 2016
1 Fc Protein and Glycoengineered Antibodies Overview
1.1 Product Overview and Scope of Fc Protein and Glycoengineered Antibodies
1.2 Classification of Fc Protein and Glycoengineered Antibodies
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Fc Protein and Glycoengineered Antibodies
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Fc Protein and Glycoengineered Antibodies Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Fc Protein and Glycoengineered Antibodies (2011-2021)
1.5.1 Global Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2021)
1.5.2 Global Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
2 Global Fc Protein and Glycoengineered Antibodies Competition by Manufacturers, Type and Application
2.1 Global Fc Protein and Glycoengineered Antibodies Market Competition by Manufacturers
2.1.1 Global Fc Protein and Glycoengineered Antibodies Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Fc Protein and Glycoengineered Antibodies Revenue and Share by Manufacturers (2011-2016)
2.2 Global Fc Protein and Glycoengineered Antibodies (Volume and Value) by Type
2.2.1 Global Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type (2011-2016)
2.2.2 Global Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2011-2016)
2.3 Global Fc Protein and Glycoengineered Antibodies (Volume and Value) by Regions
2.3.1 Global Fc Protein and Glycoengineered Antibodies Sales and Market Share by Regions (2011-2016)
2.3.2 Global Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Regions (2011-2016)
2.4 Global Fc Protein and Glycoengineered Antibodies (Volume) by Application
3 USA Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
3.1 USA Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
3.1.1 USA Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
3.1.2 USA Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
3.1.3 USA Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
3.2 USA Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
3.3 USA Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
3.4 USA Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
4 China Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
4.1 China Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
4.1.1 China Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
4.1.2 China Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
4.1.3 China Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
4.2 China Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
4.3 China Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
4.4 China Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
5 Europe Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
5.1 Europe Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
5.1.1 Europe Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
5.1.2 Europe Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
5.1.3 Europe Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
5.2 Europe Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
5.3 Europe Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
5.4 Europe Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
6 Japan Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
6.1 Japan Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
6.1.1 Japan Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
6.1.2 Japan Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
6.1.3 Japan Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
6.2 Japan Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
6.3 Japan Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
6.4 Japan Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
7 India Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
7.1 India Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
7.1.1 India Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
7.1.2 India Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
7.1.3 India Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
7.2 India Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
7.3 India Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
7.4 India Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
8 Southeast Asia Fc Protein and Glycoengineered Antibodies (Volume, Value and Sales Price)
8.1 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Value (2011-2016)
8.1.1 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
8.2 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Market Share by Manufacturers
8.3 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type
8.4 Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application
9 Global Fc Protein and Glycoengineered Antibodies Manufacturers Analysis
9.1 Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 TG Therapeutics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 126 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 MedImmune/AstraZeneca
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 142 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 LFB Biotechnologies
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oct Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Glycotope
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Mentrik Biotech
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 MacroGenics
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 MorphoSys
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
10 Fc Protein and Glycoengineered Antibodies Maufacturing Cost Analysis
10.1 Fc Protein and Glycoengineered Antibodies Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Fc Protein and Glycoengineered Antibodies Market Forecast (2016-2021)
14.1 Global Fc Protein and Glycoengineered Antibodies Sales, Revenue Forecast (2016-2021)
14.2 Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Regions (2016-2021)
14.3 Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Type (2016-2021)
14.4 Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Fc Protein and Glycoengineered Antibodies
Table Classification of Fc Protein and Glycoengineered Antibodies
Figure Global Sales Market Share of Fc Protein and Glycoengineered Antibodies by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Fc Protein and Glycoengineered Antibodies
Figure Global Sales Market Share of Fc Protein and Glycoengineered Antibodies by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure China Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure Europe Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure Japan Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure India Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Figure Global Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2021)
Figure Global Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)
Table Global Fc Protein and Glycoengineered Antibodies Sales of Key Manufacturers (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers (2011-2016)
Figure 2015 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers
Figure 2016 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers
Table Global Fc Protein and Glycoengineered Antibodies Revenue by Manufacturers (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table 2016 Global Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table Global Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales Share by Type (2011-2016)
Figure Sales Market Share of Fc Protein and Glycoengineered Antibodies by Type (2011-2016)
Figure Global Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Type (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Fc Protein and Glycoengineered Antibodies by Type (2011-2016)
Figure Global Fc Protein and Glycoengineered Antibodies Revenue Growth Rate by Type (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales and Market Share by Regions (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales Share by Regions (2011-2016)
Figure Sales Market Share of Fc Protein and Glycoengineered Antibodies by Regions (2011-2016)
Figure Global Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Regions (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Regions (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Fc Protein and Glycoengineered Antibodies by Regions (2011-2016)
Figure Global Fc Protein and Glycoengineered Antibodies Revenue Growth Rate by Regions (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application (2011-2016)
Table Global Fc Protein and Glycoengineered Antibodies Sales Share by Application (2011-2016)
Figure Sales Market Share of Fc Protein and Glycoengineered Antibodies by Application (2011-2016)
Figure Global Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2011-2016)
Figure USA Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure USA Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure USA Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table USA Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Figure Europe Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure Europe Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure Europe Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table Europe Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Figure Japan Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure Japan Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure Japan Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table Japan Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Figure India Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure India Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure India Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table India Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Figure Southeast Asia Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2016)
Figure Southeast Asia Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Fc Protein and Glycoengineered Antibodies Sales Price Trend (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Sales by Manufacturers (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Market Share by Manufacturers (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Market Share by Type (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)
Table Southeast Asia Fc Protein and Glycoengineered Antibodies Market Share by Application (2011-2016)
Table Roche Basic Information List
Table Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table TG Therapeutics Basic Information List
Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure TG Therapeutics Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table MedImmune/AstraZeneca Basic Information List
Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table LFB Biotechnologies Basic Information List
Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table Glycotope Basic Information List
Table Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Glycotope Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table Mentrik Biotech Basic Information List
Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mentrik Biotech Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table MacroGenics Basic Information List
Table MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MacroGenics Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table MorphoSys Basic Information List
Table MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MorphoSys Fc Protein and Glycoengineered Antibodies Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fc Protein and Glycoengineered Antibodies
Figure Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies
Figure Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
Table Major Buyers of Fc Protein and Glycoengineered Antibodies
Table Distributors/Traders List
Figure Global Fc Protein and Glycoengineered Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Global Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate Forecast (2016-2021)
Table Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Regions (2016-2021)
Table Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Type (2016-2021)
Table Global Fc Protein and Glycoengineered Antibodies Sales Forecast by Application (2016-2021)
  • Therapies for Resistant and Recurrent Metastatic Cancer
    Published: 06-Nov-2017        Price: US 4950 Onwards        Pages: 338
    The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. The lung cancer market is expected to grow from $15.7 billion in 2017 to $22.6 billion in 2022 at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 at a CAGR of 7.7% for the period 2017-20......
  • Healthcare Analytics: Technologies and Global Markets
    Published: 31-Oct-2017        Price: US 4950 Onwards        Pages: 105
    The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%. The financial analytics market segment is projected to grow from $3.0 billion in 2017 to nearly $5.3 billion in 2020 at a CAGR of 11.9% for the period 2017-2022. The clinical analytics market segment is expected to grow from nearly $2.8 billion in 2017 to $6.2 billion by 2022, incre......
  • Medication Adherence: Systems, Technologies and Global Markets
    Published: 09-Oct-2017        Price: US 4950 Onwards        Pages: 166
    The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021. United States market for medication adherence is expected to grow from $954 million in 2016 to nearly $2.1 billion at a CAGR of 17.5% from 2016 through 2021. Asia market for medication adherence is expected to grow from $225 million in 2016 to $555 million in 2021 at a CAGR of 19.8% from 2016 th......
  • Biologic and Medical Imaging Reagents: Global Markets
    Published: 05-Oct-2017        Price: US 4950 Onwards        Pages: 286
    The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. The radioactive imaging market will grow from $4.2 billion in 2017 to nearly $8.4 billion by 2022 with a CAGR of 14.7%. The optical imaging market will grow from $4.9 billion in 2017 to around $7.9 billion by 2022 with a CAGR of 9.8%.......
  • Nanotechnology in Medical Applications: The Global Market
    Published: 29-Sep-2017        Price: US 4950 Onwards        Pages: 121
    The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017. Nanomedicine market for anticancers is projected to grow at a CAGR of 12.3% from 2017 to 2022, and should reach $84.4 billion by 2022 from $47.3 billion in 2017. Nanomedicine market for CNS products is projected to grow at a CAGR of 18.2% and s......
  • Medical Device Security: Technologies and Global Markets
    Published: 27-Sep-2017        Price: US 5500 Onwards        Pages: 140
    The global market for medical device security totaled $4.7 billion in 2016. The market should total $5.2 billion in 2017 and $7.5 billion by 2022, increasing at a compound annual growth rate (CAGR) 7.4% from 2017 to 2022. The hardware segment market for medical device security totaled $2.8 billion in 2016. The market should total over $3.0 billion in 2017 and $4.2 billion by 2022, increasing at a CAGR of 6.7% from 2017 to 2022. The software segment market for medical device securit......
  • Disposable Medical Sensors: Technologies and Global Markets
    Published: 13-Sep-2017        Price: US 4950 Onwards        Pages: 147
    The global market for disposable medical sensors reached $5.1 billion in 2016. The market should reach $5.6 billion in 2017 and $9.0 billion by 2022, at a five-year compound annual growth rate (CAGR) of 10.0% from 2017 to 2022. The North American disposable medical sensors market should reach $2.0 billion in 2017 and $3.1 billion by 2022, at a CAGR of 8.7% from 2017 to 2022. Asia-Pacific market for disposable medical sensors totaled nearly $1.5 billion in 2017 and $2.5 billion by 2......
  • Global and Chinese Dopamine Agonist Industry, 2017 Market Research Report
    Published: 04-Sep-2017        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Dopamine Agonist Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Dopamine Agonist industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dopamine Agonist manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its def......
  • Substance Abuse, Addiction, and Treatment: Global Markets
    Published: 31-Aug-2017        Price: US 3950 Onwards        Pages: 150
    The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%. The drug abuse segment reached nearly $2.3 billion in 2016 and should reach $3.1 billion by 2021, at a CAGR of 6.8%. Nicotine abuse segment reached $758 million in 2016 and should reach nearly $1.1 billion by 2021, at a CAGR of 7.3%. Companies Mentioned Alkermes Plc ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs